Combination treatments in Alzheimer’s disease: risks and benefits

Ginkgo bilobaextract EGb 761®, donepezil or both combined in the treatment of Alzheimer's disease with neuropsychiatric features: A randomised, double-blind, exploratory trial

(2009) S. Yancheva et al.   AGING & MENTAL HEALTH

Memantine Therapy for Alzheimer Disease in Real-world Practice

(2009) Jean-Sébastien Vidal et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Defining and labeling disease-modifying treatments for Alzheimer's disease

(2009) Jeffrey L. Cummings   Alzheimers & Dementia

AddNeuroMed-The European Collaboration for the Discovery of Novel Biomarkers for Alzheimer's Disease

(2009) Simon Lovestone et al.   Annals of the New York Academy of Sciences

Steady-State Pharmacokinetics of Rivastigmine in Patients with Mild to Moderate Alzheimer’s Disease Not Affected by Co-Administration of Memantine

(2009) Joshua Shua-Haim et al.   CLINICAL DRUG INVESTIGATION

Cholinesterase Inhibitors and Beyond

(2009) Giancarlo Pepeu et al.   Current Alzheimer Research

Long-term treatment of patients with Alzheimer's disease in primary and secondary care: results from an international survey

(2009) Lutz Froelich et al.   CURRENT MEDICAL RESEARCH AND OPINION

A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimer’s disease: a post hoc analysis

(2009) Martin R. Farlow et al.   CURRENT MEDICAL RESEARCH AND OPINION

Cholinesterase inhibition: is there evidence for disease-modifying effects?

(2009) Michael Shanks et al.   CURRENT MEDICAL RESEARCH AND OPINION

Vitamin E Use Is Associated with Improved Survival in an Alzheimer’s Disease Cohort

(2009) Valory N. Pavlik et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

The role of nutrition in Alzheimer’s disease: epidemiological evidence

(2009) M. C. Morris   EUROPEAN JOURNAL OF NEUROLOGY

Safety and tolerability of rivastigmine capsule with memantine in patients with probable Alzheimer's disease: a 26-week, open-label, prospective trial (Study ENA713B US32)

(2009) Jason T. Olin et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Adherence to a Mediterranean Diet, Cognitive Decline, and Risk of Dementia

(2009) Catherine Féart   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer DiseaseA Randomized Controlled Trial

(2009) Robert C. Green   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Physical Activity, Diet, and Risk of Alzheimer Disease

(2009) Nikolaos Scarmeas   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease

(2009) O L Lopez et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Treatment Practices of Mild Cognitive Impairment in California Alzheimer's Disease Centers

(2009) Andrea M. Weinstein et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Therapeutic potential of statins in Alzheimer's disease

(2009) Nagaendran Kandiah et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Alzheimer's Disease Neuroimaging Initiative (ADNI): Clinical characterization

(2009) R. C. Petersen et al.   NEUROLOGY

Cholinergic direct inhibition ofN-methyl-D aspartate receptor-mediated currents in the rat neocortex

(2009) Jorge Flores-Hernandez et al.   SYNAPSE

DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease – a multicentre RCT

(2009) Rob Jones et al.   Trials

Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease

(2009) Susan D Rountree et al.   Alzheimers Research & Therapy

Long-term Course and Effectiveness of Combination Therapy in Alzheimer Disease

(2008) Alireza Atri et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

The Atorvastatin/Donepezil in Alzheimer’s Disease Study (LEADe): Design and baseline characteristics

(2008) Roy W. Jones et al.   Alzheimers & Dementia

Reviews: Current Concepts in Alzheimer's Disease: A Multidisciplinary Review

(2008) Ludovico Minati et al.   American Journal of Alzheimers Disease and Other Dementias

Memantine Treatment in Patients with Mild to Moderate Alzheimers Disease Already Receiving a Cholinesterase Inhibitor: A Randomized, Double-Blind, Placebo-Controlled Trial

(2008) Anton Porsteinsson et al.   Current Alzheimer Research

Pharmacodynamics of Memantine: An Update

(2008) C. Parsons et al.   Current Neuropharmacology

Dementia of the Alzheimer Type

(2008) J. J. Jalbert et al.   EPIDEMIOLOGIC REVIEWS

High-Dose B Vitamin Supplementation and Cognitive Decline in Alzheimer Disease

(2008) Paul S. Aisen   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study

(2008) Rachelle S Doody et al.   LANCET

Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial

(2008) Gordon K Wilcock et al.   LANCET NEUROLOGY

Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease

(2008) M PAKASKI et al.   NEUROCHEMISTRY INTERNATIONAL

Glutamatergic Approaches to the Treatment of Cognitive and Behavioural Symptoms of Alzheimer’s Disease

(2008) Paul T. Francis   Neurodegenerative Diseases

Alternative Medicine and Alzheimer Disease

(2008) Brendan J. Kelley et al.   NEUROLOGIST

No Effect of One-Year Treatment with Indomethacin on Alzheimer's Disease Progression: A Randomized Controlled Trial

(2008) Daniëlle de Jong et al.   PLoS One

A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease

(2007) Peter J. Connelly et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms

(2007) Yvonne Freund-Levi et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY